nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of brain metastases from male breast cancer responding to tamoxifen
|
van Rijswijk, R.E.N. |
|
1997 |
33 |
13 |
p. 2282-2283 2 p. |
artikel |
2 |
Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome
|
Muller, D. |
|
1997 |
33 |
13 |
p. 2203-2210 8 p. |
artikel |
3 |
A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast
|
Gregory, R.K. |
|
1997 |
33 |
13 |
p. 2194-2197 4 p. |
artikel |
4 |
Basic population and cancer genetics and their use in the assessment of cancer risk
|
Lyman, G.H. |
|
1997 |
33 |
13 |
p. 2160-2166 7 p. |
artikel |
5 |
Calendar of forthcoming meetings
|
|
|
1997 |
33 |
13 |
p. I-II nvt p. |
artikel |
6 |
Cancer survival from incident cases of a population-based study in the Umbria Region, Italy
|
La Rosa, F. |
|
1997 |
33 |
13 |
p. 2241-2245 5 p. |
artikel |
7 |
Chemotherapy for metastatic breast cancer —When is enough enough?
|
Stockler, M. |
|
1997 |
33 |
13 |
p. 2147-2148 2 p. |
artikel |
8 |
Clinicians' attitudes to clinical trials of cancer therapy
|
Fallowfield, L. |
|
1997 |
33 |
13 |
p. 2221-2229 9 p. |
artikel |
9 |
Commentary
|
Stevens, M. |
|
1997 |
33 |
13 |
p. 2234-2236 3 p. |
artikel |
10 |
Co-segregation of BRCA1 185delAG mutation and BRCA2 6174delT in one single family
|
Gershoni-Baruch, R. |
|
1997 |
33 |
13 |
p. 2283-2284 2 p. |
artikel |
11 |
Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative group
|
Sahmoud, T. |
|
1997 |
33 |
13 |
p. 2211-2215 5 p. |
artikel |
12 |
Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (il-6), interleukin-lβ (IL-Iβ), interleukin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas
|
Asschert, J.G.W. |
|
1997 |
33 |
13 |
p. 2246-2251 6 p. |
artikel |
13 |
Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia
|
Sebestyén, A. |
|
1997 |
33 |
13 |
p. 2273-2277 5 p. |
artikel |
14 |
Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity
|
Van Kuilenburg, A.B.P. |
|
1997 |
33 |
13 |
p. 2258-2264 7 p. |
artikel |
15 |
Immunohistochemical determination of thymidylate synthase in colorectal cancer—methodological studies
|
Edler, D. |
|
1997 |
33 |
13 |
p. 2278-2281 4 p. |
artikel |
16 |
International cancer news
|
|
|
1997 |
33 |
13 |
p. 2141-2146 6 p. |
artikel |
17 |
Is it reasonable to select the median value of T pot as a cut-off level in prediction of the radiation treatment outcome?
|
Suwinski, R. |
|
1997 |
33 |
13 |
p. 2284-2285 2 p. |
artikel |
18 |
Ki-ras oncogene and p53 tumour suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model
|
Pauly, M. |
|
1997 |
33 |
13 |
p. 2265-2272 8 p. |
artikel |
19 |
Phase II study of semisynthetic paclitaxel in metastatic breast cancer
|
Hudis, C. |
|
1997 |
33 |
13 |
p. 2198-2202 5 p. |
artikel |
20 |
Phase II trials of docetaxel (taxotere®) in advanced ovarian cancer—an updated overview
|
Kaye, S.B. |
|
1997 |
33 |
13 |
p. 2167-2170 4 p. |
artikel |
21 |
Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer
|
Painbeni, T. |
|
1997 |
33 |
13 |
p. 2216-2220 5 p. |
artikel |
22 |
Review of recent trials of chemotherapy for advanced breast cancer: Studies excluding taxanes
|
Demons, M. |
|
1997 |
33 |
13 |
p. 2171-2182 12 p. |
artikel |
23 |
Review of recent trials of chemotherapy for advanced breast cancer: the taxanes
|
Clemons, M. |
|
1997 |
33 |
13 |
p. 2183-2193 11 p. |
artikel |
24 |
Short- and long-term oestradiol treatment inhibits growth and alters expression ofp21WAF1/cip1 in an endometrial adenocarcinoma cell line lacking functional p53
|
Karlsson, L. |
|
1997 |
33 |
13 |
p. 2252-2257 6 p. |
artikel |
25 |
Should prophylactic surgery be used in women with a high risk of breast cancer?
|
Janin, N. |
|
1997 |
33 |
13 |
p. 2153-2158 6 p. |
artikel |
26 |
Should prophylactic surgery be used in women with a high risk of breast cancer?
|
Cortés-Funes, Hernán |
|
1997 |
33 |
13 |
p. 2158-2159 2 p. |
artikel |
27 |
Should prophylactic surgery be used in women with a high risk of breast cancer?
|
Klijn, Jan G.M. |
|
1997 |
33 |
13 |
p. 2149-2153 5 p. |
artikel |
28 |
Soft tissue sarcomas
|
Womer, R.B. |
|
1997 |
33 |
13 |
p. 2230-2234 5 p. |
artikel |
29 |
The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: A population-based cohort study
|
Bratt, O. |
|
1997 |
33 |
13 |
p. 2237-2240 4 p. |
artikel |